Delivery Order SPE2DB20D7066-SPE2DB25FC4MD
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $3,693.91. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 10, 2025, and was awarded on a competitive basis without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $3,928.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (30 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,155.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of HYZAAR 100-12.5, a combination antihypertensive medication, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,297.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Hyzaar 50-12.5, a combination antihypertensive medication. This non-set-aside competitive award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $341,650 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599439 HYZAAR 100-12.5 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets of the specified hypertension medication to a facility in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on the Agency's Pharmaceutical Prime Vendor contract,...
- This is a $1,592.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYZAAR 50-12.5 TABLET 90S, a medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4MDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,435.70 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of HYZAAR 50-12.5 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting the vendor's demonstrated capability to compete openly in federal medical supply markets. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally in support of military healthcare programs and federal medical procurement needs. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism, positioning it as a critical vendor for federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 8/25/25 |